Article Text

Download PDFPDF
Unexpected outcome (positive or negative) including adverse drug reactions
Acute community acquired Aspergillus pneumonia in a presumed immunocompetent host
  1. Varun Sridhar1,
  2. Natarajan Rajagopalan2,
  3. Shivaprasad C3,
  4. Mahantesh Patil3,
  5. Jaicob Varghese3
  1. 1Internal Medicine Department, Narayana Hrudayalaya Hospital, Bangalore, Karnataka, India
  2. 2Pulmonology and Critical Care Department, Narayana Hrudayalaya Hospital, Bangalore, Karnataka, India
  3. 3Critical Care Services Department, Narayana Hrudayalaya Hospital, Bangalore, India
  1. Correspondence to Natarajan Rajagopalan, gopanya{at}hotmail.com

Summary

Infection from Aspergillus results in a wide range of diseases from simple Aspergillus pneumonia to fatal invasive Aspergillosis. Though the fungus is known to predominantly affect the immunocompromised host, it has also been known to cause acute pneumonia in immunocompetent hosts which is invariably fatal. It presents as an acute pneumonia with bilateral chest infiltrates on radiograph. Early clinical suspicion and microbiological identification by measures such as broncho alveolar lavage and initiation of therapy with voricanozole significantly increase the chances of survival. In this article the authors discuss a case of acute community acquired Aspergillus pneumonia in an immunocompetent host who survived due to early identification and prompt treatment with appropriate antifungal medication.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests None.

  • Patient consent Obtained.